简体中文|English
Trial search Nation, Province(City) Code of disease Primary sponsor(s) Secondary sponsor(s) Funding source Recruiting status Register status Measure Ethical committee Study type
Measure statistics in Global
Year：

None

Check the details 33707(13.49%)

Nil

Check the details 5890(2.36%)

NA

Check the details 5272(2.11%)

Not filled

Check the details 4819(1.93%)

no

Check the details 4454(1.78%)

N/A

Check the details 4321(1.73%)

placebo

Check the details 1525(0.61%)

No intervention

Check the details 1383(0.55%)

Check the details 648(0.26%)

acupuncture

Check the details 467(0.19%)

Usual care

Check the details 396(0.16%)

Routine care

Check the details 361(0.14%)

Normal saline

Check the details 346(0.14%)

Health Education

Check the details 297(0.12%)

propofol

Check the details 295(0.12%)

Conventional treatment

Check the details 294(0.12%)

nothing

Check the details 254(0.10%)

Conventional therapy

Check the details 251(0.10%)

Not applicable

Check the details 248(0.10%)

dexmedetomidine

Check the details 230(0.09%)

Null

Check the details 230(0.09%)

SURGERY

Check the details 212(0.08%)

general anesthesia

Check the details 204(0.08%)

Sham stimulation

Check the details 200(0.08%)

Routine treatment

Check the details 195(0.08%)

Non

Check the details 176(0.07%)

Sham acupuncture

Check the details 167(0.07%)

chemotherapy

Check the details 157(0.06%)

Basic treatment

Check the details 149(0.06%)

Blank control

Check the details 144(0.06%)

Saline

Check the details 140(0.06%)

Electroacupuncture

Check the details 138(0.06%)

None

Check the details 137(0.05%)

conventional treatment

Check the details 131(0.05%)

standard treatment

Check the details 116(0.05%)

Esketamine

Check the details 109(0.04%)

Blank

Check the details 107(0.04%)

non-intervention

Check the details 103(0.04%)

rTMS

Check the details 102(0.04%)

Routine nursing

Check the details 102(0.04%)

control

Check the details 94(0.04%)

observation

Check the details 93(0.04%)

sufentanil

Check the details 93(0.04%)

medication

Check the details 89(0.04%)

Remimazolam

Check the details 88(0.04%)

Metformin

Check the details 87(0.03%)

Oral placebo

Check the details 86(0.03%)

Probiotics

Check the details 85(0.03%)

Radiotherapy

Check the details 79(0.03%)

Aerobic exercise

Check the details 78(0.03%)

None.

Check the details 74(0.03%)

No treatment

Check the details 69(0.03%)

Western medicine

Check the details 67(0.03%)

Apatinib

Check the details 67(0.03%)

no interventions

Check the details 66(0.03%)

sevoflurane

Check the details 66(0.03%)

Ropivacaine

Check the details 59(0.02%)

ciprofol

Check the details 58(0.02%)

Case series

Check the details 58(0.02%)

repetitive transcranial magnetic stimulation

Check the details 58(0.02%)

Routine health education

Check the details 56(0.02%)

Drug

Check the details 52(0.02%)

conventional care

Check the details 52(0.02%)

Standard care

Check the details 51(0.02%)

control group

Check the details 51(0.02%)

operation

Check the details 50(0.02%)

routine rehabilitation

Check the details 50(0.02%)

Maltodextrin

Check the details 50(0.02%)

exercise

Check the details 50(0.02%)

Repetitive transcranial magnetic stimulation

Check the details 48(0.02%)

moxibustion

Check the details 47(0.02%)

Drug Therapy

Check the details 46(0.02%)

treatment as usual

Check the details 45(0.02%)

TACE

Check the details 45(0.02%)

Conventional rehabilitation

Check the details 45(0.02%)

conventional nursing

Check the details 45(0.02%)

Tai Chi

Check the details 44(0.02%)

transcranial magnetic stimulation

Check the details 43(0.02%)

Conventional rehabilitation

Check the details 43(0.02%)

Routine rehabilitation training

Check the details 42(0.02%)

fecal microbiota transplantation

Check the details 41(0.02%)

N

Check the details 41(0.02%)

remifentanil

Check the details 41(0.02%)

无

Check the details 40(0.02%)

Routine management

Check the details 40(0.02%)

stellate ganglion block

Check the details 40(0.02%)

medicine

Check the details 39(0.02%)

remazolam

Check the details 39(0.02%)

sham rTMS

Check the details 39(0.02%)

Routine rehabilitation training

Check the details 38(0.02%)

Surgical treatment

Check the details 38(0.02%)

anlotinib

Check the details 37(0.01%)

Routine rehabilitation

Check the details 36(0.01%)

tDCS

Check the details 36(0.01%)

midazolam

Check the details 36(0.01%)

Baduanjin

Check the details 35(0.01%)

without intervention

Check the details 35(0.01%)

Laparoscopic surgery

Check the details 35(0.01%)

Lidocaine

Check the details 35(0.01%)

Drug treatment

Check the details 35(0.01%)
欢迎访问WHO国际临床试验注册平台 Clinical Trials Hong Kong

Chinese Clinical Trial Registry, Primary Registry of WHO International Clinical Trials Registry Platform

Copyright(c) (2005 - 2023) Chictr.org.cn.All rights reserved. Chinese Clinical Trial Registry

蜀ICP备16010396号-9

Note: It is recommended to use the widescreen display resolution of Internet Explorer 8.0 or later